Merck & Company Inc - Research and Development

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Research-and-Development" stands at 16.25 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 06/30/2023.

Merck & Company Inc's third quarter result of 4.00 Billion USD for the item "Research and Development" represents a decrease of -1.26 percent compared to it's second quarter result.

Also, Merck & Company Inc's third quarter result of 4.00 Billion USD for the item "Research and Development" represents a decrease of -31.82 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 16.25 Billion USD for the item "Research and Development" represents a decrease of -10.30 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -29.29 percent compared to the value the year prior.
The 1 year change in percent is -29.29.
The 3 year change in percent is 26.55.
The 5 year change in percent is 59.45.
The 10 year change in percent is 126.01.

The Serie's long term average value is 12.03 Billion United States Dollars. It's latest available value, on 09/30/2025, is 35.03 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2016, to it's latest available value, on 09/30/2025, is +145.21%.
The Serie's change in percent from it's maximum value, on 12/31/2023, to it's latest available value, on 09/30/2025, is -46.78%.